Exact Mass: 325.1103

Exact Mass Matches: 325.1103

Found 66 metabolites which its exact mass value is equals to given mass value 325.1103, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-Glycolylneuraminic acid

(2S,4S,5R,6R)-2,4-dihydroxy-5-(2-hydroxyacetamido)-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid

C11H19NO10 (325.1009)


N-Glycolylneuraminic acid (Neu5Gc) is a widely expressed sialic acid found in most mammalian cells. Although humans are genetically deficient in producing Neu5Gc, small amounts are present in human cells and biofluids. Humans cannot synthesize Neu5Gc because the human gene CMAH is irreversibly mutated, though it is found in apes. This loss of the CMAH gene was estimated to have occurred two to three million years ago, just before the emergence of the genus Homo. A dietary origin of Neu5Gc was suggested by human volunteer studies. These trace amounts of Neu5Gc were determined to come from the consumption of animals in the human diet (i.e. red meats such as lamb, pork, and beef). Neu5Gc can also be found in dairy products, but to a lesser extent. Neu5Gc is not found in poultry and is found in only trace amounts in fish (Wikipedia). Isolated from beef serum KEIO_ID G062

   

NeuNGc

(4S,5R,6R)-2,4-dihydroxy-5-(2-hydroxyacetamido)-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid

C11H19NO10 (325.1009)


NeuNGc, also known as N-Glycolylneuraminic acid or Neu5GC, is classified as a member of the N-acylneuraminic acids. N-acylneuraminic acids are neuraminic acids carrying an N-acyl substituent. NeuNGc is considered to be soluble (in water) and acidic

   

(2R,4R,5S,6S)-2,4-Dihydroxy-5-[(2-hydroxyacetyl)amino]-6-[(1S,2S)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid

(2S,4S,5R,6R)-2,4-Dihydroxy-5-(2-hydroxyacetamido)-6-((1R,2R)-1,2,3-trihydroxypropyl)tetrahydro-2H-pyran-2-carboxylate

C11H19NO10 (325.1009)


Isolated from beef serum

   

o6-Carboxymethyl-2'-deoxy-guanosine

2-({9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-imino-3,9-dihydro-2H-purin-6-yl}oxy)acetate

C12H15N5O6 (325.1022)


   
   

O6-CM-dG

O6-CM-dG

C12H15N5O6 (325.1022)


consensus spectrum

   

Benzyl glycoside,N-Ac-alpha-D-pyranose-2-Amino-2-deoxymannuronic acid

Benzyl glycoside,N-Ac-alpha-D-pyranose-2-Amino-2-deoxymannuronic acid

C15H19NO7 (325.1161)


   

[5-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl acetate

[5-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl acetate

C12H15N5O6 (325.1022)


   

(4-hydroxy-3-methoxyphenyl)acetonitrile 4-O-beta-D-glucopyranoside|4-hydroxy-3-methoxyphenylacetonitrile 4-O-beta-D-glucopyranoside|adenophoraside A|hydranitriloside B1|[4-(beta-D-glucopyranosyloxy)-3-methoxyphenyl]acetonitrile

(4-hydroxy-3-methoxyphenyl)acetonitrile 4-O-beta-D-glucopyranoside|4-hydroxy-3-methoxyphenylacetonitrile 4-O-beta-D-glucopyranoside|adenophoraside A|hydranitriloside B1|[4-(beta-D-glucopyranosyloxy)-3-methoxyphenyl]acetonitrile

C15H19NO7 (325.1161)


   

(3-hydroxy-4-methoxyphenyl)acetonitrile 3-O-beta-D-glucopyranoside|hydranitriloside A2|[3-(beta-D-glucopyranosyloxy)-4-methoxyphenyl]acetonitrile

(3-hydroxy-4-methoxyphenyl)acetonitrile 3-O-beta-D-glucopyranoside|hydranitriloside A2|[3-(beta-D-glucopyranosyloxy)-4-methoxyphenyl]acetonitrile

C15H19NO7 (325.1161)


   

desulfo-4-(methylsulfanyl)butyl GL|desulfoglucoerucin|DS-GER

desulfo-4-(methylsulfanyl)butyl GL|desulfoglucoerucin|DS-GER

C12H23NO5S2 (325.1018)


   

2-cyano-3-hydroxy-4-methylbenzenemethanol-7-O-beta-D-glucopyranoside|crenulatanoside A

2-cyano-3-hydroxy-4-methylbenzenemethanol-7-O-beta-D-glucopyranoside|crenulatanoside A

C15H19NO7 (325.1161)


   

SCHEMBL22748803

SCHEMBL22748803

C11H19NO10 (325.1009)


   
   
   

O6-Carboxymethyl-deoxyguanosine

O6-Carboxymethyl-deoxyguanosine

C12H15N5O6 (325.1022)


   

Citalopram (propionic acid derivative)

Citalopram (propionic acid derivative)

C19H16FNO3 (325.1114)


   
   
   
   
   
   
   

N-Glycolylneuraminic acid

N-Glycolyl-Neuraminic acid

C11H19NO10 (325.1009)


   
   

TRANS-1-(TERT-BUTOXYCARBONYL)-4-(4-CHLOROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID

TRANS-1-(TERT-BUTOXYCARBONYL)-4-(4-CHLOROPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID

C16H20ClNO4 (325.1081)


   

Boc-trans-DL-b-Pro-4-(4-chlorophenyl)-OH

Boc-trans-DL-b-Pro-4-(4-chlorophenyl)-OH

C16H20ClNO4 (325.1081)


   

1,3-bis(3,3,3-trifluoropropyl)tetramethyldisilazane

1,3-bis(3,3,3-trifluoropropyl)tetramethyldisilazane

C10H21F6NSi2 (325.1117)


   

2H-1,4-Benzodiazepin-2-one,1,3-dihydro-1-(methoxymethyl)-7-nitro-5-phenyl-

2H-1,4-Benzodiazepin-2-one,1,3-dihydro-1-(methoxymethyl)-7-nitro-5-phenyl-

C17H15N3O4 (325.1063)


   
   

4-(3-chlorophenyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-3-carboxylic acid

4-(3-chlorophenyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-3-carboxylic acid

C16H20ClNO4 (325.1081)


   

Ethyl 5-hydroxy-8-methyl-7-oxo-2-phenyl-7,8-dihydropyrido[2,3-d]pyrimidine-6-carboxylate

Ethyl 5-hydroxy-8-methyl-7-oxo-2-phenyl-7,8-dihydropyrido[2,3-d]pyrimidine-6-carboxylate

C17H15N3O4 (325.1063)


   

N-METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE

N-METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE

C16H20ClNO4 (325.1081)


   

2-formylphenyl 2-acetamido-2-deoxy-beta-d-glucopyranoside

2-formylphenyl 2-acetamido-2-deoxy-beta-d-glucopyranoside

C15H19NO7 (325.1161)


   

3-benzoyl-2-phenyl-1H-quinolin-4-one

3-benzoyl-2-phenyl-1H-quinolin-4-one

C22H15NO2 (325.1103)


   

2,3-O-Isopropylidene-4-alpha-azido-uridine

2,3-O-Isopropylidene-4-alpha-azido-uridine

C12H15N5O6 (325.1022)


   

2-BIPHENYL-4-YL-QUINOLINE-4-CARBOXYLICACID

2-BIPHENYL-4-YL-QUINOLINE-4-CARBOXYLICACID

C22H15NO2 (325.1103)


   

Chloropyramine hydrochloride

Chloropyramine hydrochloride

C16H21Cl2N3 (325.1112)


D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Chloropyramine hydrochloride is a histamine receptor H1 antagonist which can also inhibit the biochemical function of VEGFR-3 and FAK.

   

Theophylline, 8-(2-pyrrolidinoethyl)thio-6-thio-

Theophylline, 8-(2-pyrrolidinoethyl)thio-6-thio-

C13H19N5OS2 (325.1031)


   

3-(2-Methoxyphenyl)-6-(3-nitrophenyl)-1,4-dihydropyrimidin-2-one

3-(2-Methoxyphenyl)-6-(3-nitrophenyl)-1,4-dihydropyrimidin-2-one

C17H15N3O4 (325.1063)


   

3-[5-(dimethylsulfamoyl)-1-ethyl-1H-1,3-benzodiazol-2-yl]propanoic acid

3-[5-(dimethylsulfamoyl)-1-ethyl-1H-1,3-benzodiazol-2-yl]propanoic acid

C14H19N3O4S (325.1096)


   

N2-(4-methylphenyl)-6-[(2-pyrimidinylthio)methyl]-1,3,5-triazine-2,4-diamine

N2-(4-methylphenyl)-6-[(2-pyrimidinylthio)methyl]-1,3,5-triazine-2,4-diamine

C15H15N7S (325.111)


   

(E)-2-cyano-N-(3-imidazol-1-ylpropyl)-3-(4-nitrophenyl)prop-2-enamide

(E)-2-cyano-N-(3-imidazol-1-ylpropyl)-3-(4-nitrophenyl)prop-2-enamide

C16H15N5O3 (325.1175)


   

6,7-dimethyl-8-(1-D-ribityl)lumazine(1-)

6,7-dimethyl-8-(1-D-ribityl)lumazine(1-)

C13H17N4O6- (325.1148)


The anion formed from 6,7-dimethyl-8-(1-D-ribityl)lumazine by removal of a proton from the nitrogen at position 3 (i.e. between the oxo groups). It is the major species at physiological pH.

   

2-Amino-4-[5-(2-amino-2-carboxylatoethyl)-2-hydroxyphenyl]pentanedioate

2-Amino-4-[5-(2-amino-2-carboxylatoethyl)-2-hydroxyphenyl]pentanedioate

C14H17N2O7- (325.1036)


   

2-Amino-4-[3-(2-amino-2-carboxylatoethyl)-6-oxocyclohexa-1,4-dien-1-yl]pentanedioate

2-Amino-4-[3-(2-amino-2-carboxylatoethyl)-6-oxocyclohexa-1,4-dien-1-yl]pentanedioate

C14H17N2O7- (325.1036)


   
   

N-[[3-chloro-2-(1-pyrrolidinyl)anilino]-sulfanylidenemethyl]butanamide

N-[[3-chloro-2-(1-pyrrolidinyl)anilino]-sulfanylidenemethyl]butanamide

C15H20ClN3OS (325.1016)


   

5-(3,4-dimethoxyphenyl)-N-(3-pyridinyl)-3-isoxazolecarboxamide

5-(3,4-dimethoxyphenyl)-N-(3-pyridinyl)-3-isoxazolecarboxamide

C17H15N3O4 (325.1063)


   

8-Nitro-5-[3-(trifluoromethyl)-1-piperidinyl]isoquinoline

8-Nitro-5-[3-(trifluoromethyl)-1-piperidinyl]isoquinoline

C15H14F3N3O2 (325.1038)


   

(R)-pantetheine sulfonate

(R)-pantetheine sulfonate

C11H21N2O7S- (325.1069)


   

2-[(4Z)-4-(furan-2-ylmethylidene)-2,5-dioxoimidazolidin-1-yl]-N-(4-methylphenyl)acetamide

2-[(4Z)-4-(furan-2-ylmethylidene)-2,5-dioxoimidazolidin-1-yl]-N-(4-methylphenyl)acetamide

C17H15N3O4 (325.1063)


   
   
   

7-Amido-7-deazaguanosine

7-Amido-7-deazaguanosine

C12H15N5O6 (325.1022)


   
   
   
   
   

3-[(6-acetyl-3,4,5-trihydroxyoxan-2-yl)oxy]-3a,4,7,7a-tetrahydro-1H-isoindol-1-one

3-[(6-acetyl-3,4,5-trihydroxyoxan-2-yl)oxy]-3a,4,7,7a-tetrahydro-1H-isoindol-1-one

C15H19NO7 (325.1161)


   

ethyl 4-[2-[(E)-(2,5-dioxoimidazolidin-4-ylidene)methyl]pyrrol-1-yl]benzoate

ethyl 4-[2-[(E)-(2,5-dioxoimidazolidin-4-ylidene)methyl]pyrrol-1-yl]benzoate

C17H15N3O4 (325.1063)


   

(2S,4E)-4-[2-[(2S,4R)-2-carboxy-4-hydroxypyrrolidin-1-ium-1-ylidene]ethylidene]-2,3-dihydro-1H-pyridine-2,6-dicarboxylic acid

(2S,4E)-4-[2-[(2S,4R)-2-carboxy-4-hydroxypyrrolidin-1-ium-1-ylidene]ethylidene]-2,3-dihydro-1H-pyridine-2,6-dicarboxylic acid

C14H17N2O7+ (325.1036)


   

N-glycoloyl-beta-neuraminic acid

N-glycoloyl-beta-neuraminic acid

C11H19NO10 (325.1009)


An N-acylneuraminic acid in which the acyl substituent on nitrogen is glycolyl and which has beta-configuration at the anomeric centre.

   

N-glycoloyl-alpha-neuraminic acid

N-glycoloyl-alpha-neuraminic acid

C11H19NO10 (325.1009)


An N-acylneuraminic acid in which the acyl substituent on nitrogen is glycoloyl and which has alpha-configuration at the anomeric centre.

   

n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]-3-(methylsulfanyl)prop-2-enamide

n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]-3-(methylsulfanyl)prop-2-enamide

C14H19N3O4S (325.1096)


   

(2e)-n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}-3-(methylsulfanyl)prop-2-enamide

(2e)-n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}-3-(methylsulfanyl)prop-2-enamide

C14H19N3O4S (325.1096)